Compare Bijuva to Other Hormone Therapies for Vasomotor Symptoms

June 2019

Bijuva (bye-JOO-vah, estradiol/progesterone) will compete with other hormone therapy (HT) options for hot flashes during menopause.

You'll hear that it's the first FDA-approved combo of "bioidentical" estrogen and progesterone in one oral capsule.

It's a fixed-dose combo of estradiol 1 mg and progesterone 100 mg...similar to oral Estrace plus Prometrium. These are also "bioidenticals."

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Opioids Start a Dialogue About Tapering Chronic Opioids
Infectious Diseases Curb Unnecessary UTI Screening to Avoid the Temptation to Treat
Cannabinoids Be Prepared With Answers About CBD
Gastroenterology Don't Think of Meds as a Significant Source of Gluten
Menopause Compare Bijuva to Other Hormone Therapies for Vasomotor Symptoms
Diabetes Weigh Pros and Cons of SGLT2 Inhibitors for Kidney Protection
Insomnia Explain Risk of Strange Sleep Behaviors With "Z-Drugs"
Warts Tell Patients to Be Persistent When Treating Warts
Osteoporosis Save Evenity for High-Risk Women With Osteoporosis
HIV & AIDS Expect Fewer Patients With HIV to Need Antibiotics for MAC Prophylaxis